Exposure-Response of Quizartinib Efficacy in Patients with Relapsed/Refractory AML

被引:0
|
作者
Kang, Dongwoo [1 ]
Passarell, Julie [2 ]
Abutarif, Malaz A. [1 ]
Mendell, Jeanne [1 ]
Yin, Ophelia [1 ]
机构
[1] Daiichi Sankyo Inc, Basking Ridge, NJ USA
[2] Cognigen Corp, Buffalo, NY USA
关键词
D O I
10.1182/blood-2019-122582
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Concentration–QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia
    Dongwoo Kang
    Elizabeth Ludwig
    David Jaworowicz
    Hannah Huang
    Jill Fiedler-Kelly
    Jorge Cortes
    Siddhartha Ganguly
    Samer Khaled
    Alwin Krämer
    Mark Levis
    Giovanni Martinelli
    Alexander Perl
    Nigel Russell
    Malaz Abutarif
    Youngsook Choi
    Ophelia Yin
    Cancer Chemotherapy and Pharmacology, 2021, 87 : 513 - 523
  • [32] Prognosing Efficacy of FLAG Regimen in the Treatment of Relapsed and Refractory AML
    Budaeva, I. G.
    Ovsiannikova, E. G.
    Kulemina, O. V.
    Motorin, D. V.
    Badaev, R. S.
    Zammoeva, D. B.
    Ivanov, V. V.
    Bogdanov, K. V.
    Pisotskay, O. S.
    Mirolubova, J. V.
    Nikulina, T. S.
    Alexeeva, Yu. A.
    Zaritskey, A. Yu.
    Girshova, L. L.
    ANNALS OF HEMATOLOGY, 2019, 98 : S44 - S45
  • [33] Characterization of clinical pharmacokinetics and exposure-response relationships of AMG 330, a bispecific CD33 T-cell engager antibody construct, in patients with relapsed/refractory AML.
    Agarwal, Suresh K.
    Bhagwat, Sharvari
    Mehta, Khamir
    Hindoyan, Antreas
    Stein, Anthony Selwyn
    Ravandi, Farhad
    Subklewe, Marion
    Walter, Roland B.
    Jongen-Lavrencic, Mojca
    Ossenkoppele, Gert J.
    Paschka, Peter
    Khaldoyanidi, Sophia
    Dutta, Sandeep
    Upreti, Vijay V.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] ELRANATAMAB INTEGRATED EXPOSURE-RESPONSE (ER) EFFICACY AND SAFETY ANALYSES IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) USING A CLINICAL UTILITY INDEX (CUI)
    Abdelgawad, I.
    Lon, H.
    Soltantabar, P.
    Hibma, J.
    Czibere, A.
    Wang, D.
    Elmeliegy, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S64 - S64
  • [35] Efficacy and safety of quizartinib (AC220) in patients age ≥ 70 years with FLT3-ITD positive or negative relapsed/refractory acute myeloid leukemia (AML).
    Perl, Alexander E.
    Dohner, Hartmut
    Rousselot, Philippe H.
    Marie, Jean-Pierre
    Martinelli, Giovanni
    Shah, Neil P.
    Levis, Mark J.
    Gammon, Guy
    Trone, Denise
    Cortes, Jorge E.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] Exposure-Response Relationships of the Efficacy and Safety of Ipilimumab in Patients with Advanced Melanoma
    Feng, Yan
    Roy, Amit
    Masson, Eric
    Chen, Tai-Tsang
    Humphrey, Rachel
    Weber, Jeffrey S.
    CLINICAL CANCER RESEARCH, 2013, 19 (14) : 3977 - 3986
  • [37] Tislelizumab exposure-response analyses of efficacy and safety in patients with advanced tumors
    Wu, C-Y.
    Budha, N.
    Gao, Y.
    Castro, H.
    Nkobena, A.
    Ben, Y.
    Sahasranaman, S.
    ANNALS OF ONCOLOGY, 2019, 30 : 182 - +
  • [38] Tepotinib exposure-response analyses of safety and efficacy in patients with solid tumours
    Paik, P. K.
    Xiong, W.
    Hietala, S. F.
    Nyberg, J.
    Papasouliotis, O.
    Anziano, R.
    Berghoff, K.
    Johne, A.
    Girard, P.
    Strotmann, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S494 - S495
  • [39] Tepotinib Exposure-Response Analyses of Safety and Efficacy in Patients with Solid Tumors
    Xiong, W.
    Hietala, S.
    Nyberg, J.
    Papasouliotis, O.
    Anziano, R.
    Berghoff, K.
    Johne, A.
    Girard, P.
    Strotmann, R.
    Paik, P.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S36 - S36
  • [40] Proposed Scheme for Dosing Venetoclax in Pediatric Patients with Relapsed/Refractory Acute Myeloid Leukemia: Analysis of Developmental Pharmacokinetics and Exposure-Response Relationships
    Badawi, Mohamed A.
    Gopalakrishnan, Sathej
    Engelhardt, Benjamin
    Palenski, Tammy L.
    Kim, Su Young
    Karol, Seth E.
    Rubnitz, Jeffrey E.
    Menon, Rajeev
    Salem, Ahmed Hamed
    BLOOD, 2020, 136